37 commercial payer policies list J3032. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
37 policies from 20 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti)Effective 06/01/2022 - 06/30/2023 | Jun 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Eptinezumab-jjmr (Vyepti)Effective 07/01/2021 - 05/31/2022 | Jul 1, 2021 | Prior auth requiredInferred from policy title |
| Eptinezumab-jjmr (Vyepti)Effective 07/01/2023 - 04/30/2024 | Jul 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Eptinezumab-jjmr (Vyepti)Effective 08/01/2020 - 06/30/2021 | Aug 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Vyepti (eptinezumab-jjmr) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Vyepti (eptinezumab-jjmr)Effective 05/01/2024 - 04/30/2025 | May 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Vyepti (eptinezumab-jjmr)Effective 05/01/2025 - 04/30/2026 | May 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3032 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Vyepti (Eptinezumab-Jjmr) | Sep 1, 2026 | Covered |
| Vyepti (Eptinezumab-Jjmr) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (VYEPTI) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Eptinezumab-jjmr (VYEPTI) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Eptinezumab-jjmr (Vyepti) – Minnesota Health Care Programs | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (VYEPTI) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Eptinezumab-jjmr (VYEPTI) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Vyepti (eptinezumab-jjmr) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Vyepti (eptinezumab-jjmr) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Vyepti (Eptinezumab-Jjmr) | Sep 1, 2026 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Headaches: Nonsurgical Management | Feb 16, 2024 | Covered |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (e.g., Vyepti) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab Jjmr Vyepti | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti) | Jun 2, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti); CP.CPA.345 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Eptinezumab-jjmr (Vyepti) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Vyepti (eptinezumab-jjmr) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3032 |
|---|---|---|
| Vyepti (Eptinezumab-Jjmr) | Sep 1, 2026 | Covered |